Recent Headlines & Media Mentions
Company News
The Connect-One Early Feasibility Study will evaluate the long term use of the Connexus BCI to safely restore speech and enable computer control for people with severe motor impairment
Partnerships with key academic researchers will help translate high-performing BCI technology into commercialized applications
Nov 20, 2025
Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus® Brain-Computer Interface
The study will evaluate the long-term use of Connexus BCI for its ability to safely restore speech and enable computer control for people with severe motor impairment.
Jul 17, 2025
Paradromics Adds Third Site for the Connexus® Brain-Computer Interface Clinical Study at the University of Michigan
Dr. Matthew Willsey, who performed the first-in-human Connexus BCI surgery, will serve as site investigator.
Jun 2, 2025
Paradromics Completes First-In-Human Recording with the Connexus® Brain-Computer Interface
In partnership with the University of Michigan Health, the surgery marks Paradromics’ entry into the clinical stage.
Thought Leadership
Looking for additional insights, industry findings, and scientific deep dives?